AusPAR: Secukinumab

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

22 November 2016
AusPAR Details
AusPAR
AusPAR Secukinumab (pdf, 2 MB)
AusPAR Secukinumab (docx, 4 MB)
Attachment: Product Information: Secukinumab (pdf, 481 KB)
Attachment: Product Information: Secukinumab (docx, 270 KB)
Attachment: Extract from Clinical Evaluation Report: Secukinumab (pdf, 3 MB)
Attachment: Extract from Clinical Evaluation Report: Secukinumab (docx, 3 MB)
Active Ingredient
Secukinumab
Product Name
Cosentyx / Zafrez
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Submission Number
PM-2015-00766-1-3 / 2015-00777-1-3
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
25 October 2016
Publication Date

22 November 2016
Category: 
Prescription medicines
Tags: 
AusPARs
URL: 
https://www.tga.gov.au/node/732938